Once this starts to turn around, looking like it will be a bit longer, Grabbing these. Currently around $0.64. Essentially options pricing at this point with a gap needing filled as well as they've got things in the pipeline. This could take a while, but hypothetically with a gap fill this could turn a profit of $246.31 approximately from current pricing for every 100 shares (current cost just under $64 per 100 shares).
This is just on my watchlist, not advice. This has fallen below what I expected and weekly/monthly is looking like more downside. Gonna come down to when they announce trials and things more than likely.
Neutral rn, once it turns around, Long. Risk total % to lose, 2.94% from current to 0. Upside potential up to 280% gain.
This is just on my watchlist, not advice. This has fallen below what I expected and weekly/monthly is looking like more downside. Gonna come down to when they announce trials and things more than likely.
Neutral rn, once it turns around, Long. Risk total % to lose, 2.94% from current to 0. Upside potential up to 280% gain.